Skip to content

Endoscopic Treatment of Post Surgical Biliary Tract Injury

Endoscopic Treatment of Post Surgical Biliary Tract Injury

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07345936
Acronym
EpSB
Enrollment
220
Registered
2026-01-16
Start date
2025-10-17
Completion date
2027-04-17
Last updated
2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary Tract Injuries

Keywords

Biliary tract injuries, Endoscopic treatment, Iatrogenic injuries of the bile ducts

Brief summary

The objective of this study is to determine the technical and clinical success rate of endoscopic treatment in a population presenting only with iatrogenic injuries of the bile ducts, excluding the cystic duct.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult (≥18 years old) * Subject who has had a wound of the common bile duct or intrahepatic bile ducts following hepatobiliary surgery (laparotomy or laparoscopic cholecystectomy or major or minor hepatectomy) * Subject treated in one of the associated centers between January 1, 2021, and December 31, 2024

Exclusion criteria

* Biliary wound occurring on a long cystic duct or gallbladder stump during partial cholecystectomy. * Biliary leakage complicating liver transplantation

Design outcomes

Primary

MeasureTime frameDescription
Clinical success rate of the initial endoscopic procedureImmediately after surgerySuccess rate: This is the percentage of patients for whom the treatment was successful Expressed as a percentage. Example: Out of 100 patients, if 85 improve, the success rate is 85%.
Clinical success rate at 3 months after the end of treatment3 months after the end of treatmentSuccess rate: This is the percentage of patients for whom the treatment was successful Expressed as a percentage. Example: If 100 patients are treated and 80 improve, the success rate is 80%.

Countries

France

Contacts

Primary ContactPierre MAYER, MD
pierre-emmanuel.mayer@chru-strasbourg.fr33 3.69.55.15.03

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026